PEG sensitivity in HVTN 133 and a healthy control population (Healthy Volunteers) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about how certain vaccines can affect people's polyethylene glycol (PEG) sensitivity levels. PEG is a component of several different vaccines. We want to compare blood samples from healthy volunteers to blood samples from HIV Vaccine Trials Network (HVTN) 133 participants. We hope this will help us better understand the variation of PEG sensitivity in the general population and between vaccinated and unvaccinated individuals.
What is the Condition Being Studied?
Healthy Volunteers
Who Can Participate in the Study?
Adults ages 18-50 who:
- Are in general good health
- Are not pregnant or breastfeeding
- Do not use any medications that can suppress the immune system
For more information about this study, please contact the study team at dvtustudies@duke.edu.
Age Group
Adults
What is Involved?
If you choose to join this study, you will:
- Visit our clinic up to 3 times over the course of about a month
- Have a blood draw at each visit
Each visit for a blood draw will take 15-20 minutes, and we will collect 1-2 tablespoons of blood.
Study Details
Full Title
Assessing polyethylene glycol (PEG) sensitivity in participants enrolled in HVTN 133 and a healthy control population
Principal Investigator
Emmanuel Walter
Protocol Number
IRB:
PRO00116401
NCT:
NA
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment